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Metabolic Oscillations in Pancreatic Islets Depend on the Intracellular Ca2þ
Level but Not Ca2þ Oscillations
Matthew J. Merrins,† Bernard Fendler,‡ Min Zhang,{ Arthur Sherman,k Richard Bertram,§ and Leslie S. Satin†*
†
Department of Pharmacology and Brehm Diabetes Center, University of Michigan Medical School, Ann Arbor, Michigan; ‡Department of
Physics and §Department of Mathematics and Programs in Neuroscience and Molecular Biophysics, Florida State University, Tallahassee,
Florida; {Department of Pharmacology, Virginia Commonwealth University, Richmond, Virginia; and kLaboratory of Biological Modeling,
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland

ABSTRACT Plasma insulin is pulsatile and reﬂects oscillatory insulin secretion from pancreatic islets. Although both islet Ca2þ
and metabolism oscillate, there is disagreement over their interrelationship, and whether they can be dissociated. In some
models of islet oscillations, Ca2þ must oscillate for metabolic oscillations to occur, whereas in others metabolic oscillations
can occur without Ca2þ oscillations. We used NAD(P)H ﬂuorescence to assay oscillatory metabolism in mouse islets stimulated
by 11.1 mM glucose. After abolishing Ca2þ oscillations with 200 mM diazoxide, we observed that oscillations in NAD(P)H
persisted in 34% of islets (n ¼ 101). In the remainder of the islets (66%) both Ca2þ and NAD(P)H oscillations were eliminated
by diazoxide. However, in most of these islets NAD(P)H oscillations could be restored and ampliﬁed by raising extracellular
KCl, which elevated the intracellular Ca2þ level but did not restore Ca2þ oscillations. Comparatively, we examined islets from
ATP-sensitive Kþ (KATP) channel-deﬁcient SUR1/ mice. Again NAD(P)H oscillations were evident even though Ca2þ and
membrane potential oscillations were abolished. These observations are predicted by the dual oscillator model, in which intrinsic
metabolic oscillations and Ca2þ feedback both contribute to the oscillatory islet behavior, but argue against other models that
depend on Ca2þ oscillations for metabolic oscillations to occur.

INTRODUCTION
Plasma insulin levels are normally pulsatile in mice, rats,
dogs, and humans (1–5), and oscillatory periods of 4–5 min
are observed when blood is sampled from the hepatic portal
vein (4,5). These oscillations are due to the oscillatory
activity of individual pancreatic islets (2,6), and insulin pulsatility is disturbed or lost in type 2 diabetics and their near
relatives (7–9).
The origin of oscillatory islet activity has been debated
since the first reports of periodic islet electrical activity
(10). The discovery of ATP-sensitive Kþ channels (KATP
channels) in b-cells (11,12) raised the possibility that glucose
metabolism may be oscillatory and act through KATP channels to induce oscillations in b-cell electrical activity (13).
This idea was given credence by later findings that factors
associated with glucose metabolism are often oscillatory,
and exhibit periods in the range observed for electrical
bursting and oscillations in the cytosolic Ca2þ concentration
or insulin. In particular, oscillations have been observed in
oxygen consumption (14–17), NAD(P)H (18), mitochondrial membrane potential (19,20), ATP or the ATP/ADP
ratio (21–23) and lactate release (24).
Although it is generally accepted that both cytosolic Ca2þ
and metabolism oscillate in islets, there is disagreement over
which is primary and how they interact. Two general classes
of models have emerged. In one, Ca2þ oscillations are essential for metabolic oscillations to occur; in the other, meta-
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bolic oscillations can persist in the absence of Ca2þ oscillations. Models of the first class, whether qualitative or
mathematical, are based on the reduction of mitochondrial
membrane potential by the flux of Ca2þ across the mitochondrial inner membrane (25,26), the stimulation of mitochondrial dehydrogenases by Ca2þ (27,28), or the reduction of
cytosolic ATP levels by ATP used for the pumping of
Ca2þ by Ca2þ-ATPases (29–31). In the models of Fridlyand
et al. (32,33), Ca2þ oscillations can occur in the absence of
metabolic oscillations, but metabolic oscillations only occur
in the presence of Ca2þ oscillations. Models of the second
class are based on the hypothesis that oscillations are
inherent to glycolysis (34–37) or some point downstream
of glycolysis, such as mitochondria (28). We refer to these
as intrinsic metabolic oscillations.
A key question is whether metabolic oscillations, which
occur in the presence of stimulatory glucose and are normally
accompanied by Ca2þ oscillations, can persist in the absence
of Ca2þ oscillations? Previous measurements of islet oxygen
consumption (pO2) revealed large pO2 oscillations that
were terminated by the KATP channel-opener diazoxide
(Dz) (15). Dz hyperpolarizes the islet and thus terminates islet
Ca2þ oscillations by abolishing Ca2þ channel activation. The
same result was obtained when islet NAD(P)H fluorescence
was used as an assay for metabolic oscillations (18). The
conclusion drawn from these experiments was that Ca2þ
oscillations drive metabolic oscillations, because the latter
oscillations stopped when the former were inhibited. However, there is evidence that oscillations in KATP, pO2, or
insulin persist in basal glucose (38), or in low Ca2þ (16,17).
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We report that although Dz can eliminate islet metabolic
oscillations, monitored as NAD(P)H fluorescence, in many
islets the metabolic oscillations persisted. Our model of islet
oscillatory behavior, the dual oscillator model (DOM),
predicts that in islets where Dz blocked oscillations in
NAD(P)H, subsequently raising intracellular Ca2þ could
restore the oscillations in metabolism without restoring Ca2þ
oscillations. We confirm this in the majority of cases tested
in this study. Oscillations in NAD(P)H were also clearly
evident in sulfonylurea receptor 1 (SUR1) null mice lacking
functional KATP channels, which under the conditions we
chose lack oscillations in Ca2þ or rhythmic electrical activity.
These data establish that Ca2þ oscillations are not essential
for metabolic oscillations to occur, and provide support for
models in which islet metabolic oscillations are intrinsic,
either at the level of glycolysis or at a later step in the
metabolic pathway. Unlike earlier studies, we believe these
results: 1), unify previous, and seemingly discrepant experimental observations in the islet literature; and 2), are predicted
by a single model (the DOM), while requiring only minor
quantitative variation of the model parameters.
MATERIALS AND METHODS
Isolation of mouse pancreatic islets
Experiments were carried out with male Swiss-Webster mice (25–30 g) from
Charles River Laboratories (Wilmington, MA) or SUR1/ mice (C57Bl/6
background) and littermate controls (SUR1þ/þ), which were generated by
breeding heterozygous animals generously provided by Dr. David Piston
(39). Mice were sacrificed by cervical dislocation according to the regulations of the University of Michigan Committee on Use and Care of Animals
(UCUCA). Islets were isolated from the pancreas as in Zhang et al. (40), and
maintained in culture for 1–2 days in RPMI1640 supplemented with 10%
(v/v) fetal calf serum, 100 U/mL penicillin, and 100 mg/mL streptomycin
(Invitrogen, Carlsbad, CA).

Electrophysiology
An Axopatch-200B patch-clamp amplifier (Axon Instruments, Union City,
CA) was used in the perforated patch-clamp configuration to record
membrane potential (Vm). Islets were perfused with a standard external solution containing (in mM: 115 NaCl, 5 KCl, 3 CaCl2, 2 MgCl2, 10 HEPES,
11.1 glucose; pH 7.4). Pipette tips were filled with an internal solution
(in mM: 28.4 K2SO4, 63.7 KCl, 11.8 NaCl, 1 MgCl2, 20.8 HEPES,
0.5 EGTA; pH 7.2) containing 0.1 mg/mL amphotericin B.

Monitoring metabolism using NAD(P)H
ﬂuorescence
To monitor changes in endogenous NAD(P)H levels (41–43), islets were
placed in a glass-bottomed chamber (54 mL volume) (Warner Instruments,
Hamden, CT) on an Olympus IX-71 inverted microscope equipped with
a 0.3 N.A. UPlanFL/UIS2 10 objective (Olympus America, Center Valley,
PA). The chamber was perfused at 0.3 mL/min and temperature was maintained at 33 C using inline and chamber heaters (Warner Instruments). The
recording solution was either standard physiologic saline solution (in mM:
137 NaCl, 5 KCl, 1.2 MgCl2, 0.5 NaH2PO4, 4.2 NaHCO3, 2.6 CaCl2,
10 HEPES, 2.8 glucose; pH 7.4, 310 mOsm), or higher (KCl) solutions using
equimolar replacement of NaCl. Islet autofluorescence was elicited with
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365 nm light (10 ms) using a Till Polychrome V monochromator (Till
Photonics GmbH, Graefelfing, Germany), a UG11 (330/140) exciter,
a 410DCLP beamsplitter, and a D500/100 wideband emission filter (Chroma
Technology, Rockingham, VT). NAD(P)H emission was collected with
a Photometrics QuantEM:512SC camera (Tucson, AZ) at 0.2 Hz. MetaFluor
software (Molecular Devices, Downington, PA) was used for hardware control and online analysis. In experiments on SUR1/ islets NAD(P)H was
measured using a photomultiplier mounted on an Olympus IX-50 microscope under the control of IonWizard software (IonOptix, Milton, MA).

Fura-2 imaging of intracellular calcium ([Ca2þ]i)
Islets were loaded with 5 mM Fura-2/AM (Invitrogen, Carlsbad, CA) for
20–30 min in a 95:5% air/CO2 incubator at 37 C, and then transferred to
the recording chamber. The microscope configuration was similar to that
used for NAD(P)H measurements, except that Fura-2 fluorescence was
elicited by alternating excitation wavelengths of 340 and 380 nm. Changes
in [Ca2þ]i were expressed as 340:380 ratio, and offline analysis was carried
out using MetaFluor software.

Analysis of slow metabolic oscillations by fast
Fourier transform
To determine the average period of slow NAD(P)H oscillations, islet fluorescence was measured using MetaFluor software. Data were linearly detrended
to correct for photobleaching using IgorPro (Wavemetrics, Portland, Oregon), and the fast Fourier transform (FFT) function in the MATLAB Signal
Processing Tool (The Mathworks, Natick, MA) was used to estimate power
spectral density. Islets were categorized as oscillatory only if FFT detected
a dominant period in recordings lasting >20 min, and nonoscillatory if
periods of <1 min or >15 min were predominant. Islets classified as nonoscillatory by this criterion were also nonoscillatory by visual inspection. The
dominant oscillatory period is reported for each islet.

The DOM
The DOM is a mathematical model that has been developed to account for
the diverse oscillatory patterns observed in islet membrane potential and
Ca2þ. The model has been previously described in detail (34), so the description here is brief. The DOM consists of three interacting components
representing glycolysis, mitochondrial metabolism, and plasma membrane
electrical activity and intracellular Ca2þ handling. The glycolytic component
can oscillate because of positive feedback onto phosphofructokinase-1
(PFK-1) by its product, fructose 1,6-bisphosphate (FBP). This increases
enzyme activity until the substrate is decreased below the level that supports
PFK-1 activity, reducing enzyme activity until substrate levels recover, initiating the next oscillation (44). These intrinsic glycolytic oscillations produce
slow (~5 min) oscillations in mitochondrial ATP production, which in turn
drive electrical oscillations through the KATP channels.
In addition to positive feedback onto PFK-1 by FBP, there is also negative
feedback by ATP. In fact, the model predicts that oscillations are terminated
if cytosolic [ATP] rises sufficiently. Thus, cytosolic ATP is an important
modulator of PFK-1 in the DOM. Cytosolic ATP is determined by mitochondrial ATP production and ATP hydrolysis by various cellular processes.
Some of these processes are Ca2þ dependent, such as the ATPases that move
Ca2þ into the endoplasmic reticulum or out of the cell.
A key feature of the model is that the production of metabolic oscillations
does not require Ca2þ oscillations; the oscillations are intrinsic to metabolism and can persist when Ca2þ is fixed. This is in contrast to models where
Ca2þ oscillations are essential for metabolic oscillations, in which case cell
hyperpolarization will always terminate the metabolic oscillations. The main
goal of this study was to experimentally assess the effect of blockade of
Ca2þ entry on the metabolic oscillations and compare the results obtained
to predictions of the DOM.
Biophysical Journal 99(1) 76–84
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Equations and values for all parameters except those listed in the legend
for Fig. 1 are given in Bertram et al. (34). Computer code for the model can
be downloaded from http://www.math.fsu.edu/~bertram/software/islet.

RESULTS
Mathematical models of islet oscillatory activity
can be parsed by experiments using diazoxide
to eliminate Ca2þ oscillations
Fig. 1 shows the predictions of several mathematical models
representing the effects of Dz on islet NAD(P)H oscillations
in 11.1 mM glucose. The application of Dz is simulated in
these models by maximizing GK(ATP), which is equivalent
to opening all b-cell KATP channels. Fig. 1 A shows the
prediction of a model equivalent to the simplest form of
the Keizer-Magnus model (13). Inhibiting Ca2þ oscillations
using this model abolishes metabolic oscillations because
metabolic oscillations depend exclusively on pulsatile fluxes
of Ca2þ across the mitochondrial inner membrane that in
turn depolarize the mitochondrial membrane potential and
inhibit ATP production. In the simulations shown for the
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Keizer-Magnus model, metabolic oscillations appear as
oscillations in ADP.
Fig. 1 B shows a similar result, in this case predicted by the
model of Fridlyand et al. (32,33). In contrast to the KeizerMagnus model, Ca2þ oscillations do not require metabolic
oscillations (not shown), but in common with Keizer-Magnus, the metabolic oscillations result from periodic increases
in cytosolic Ca2þ. In the Fridlyand model, pulsatile increases
in cytosolic Ca2þ influence metabolism by increasing ATP
consumption by Ca2þ- and Naþ/Kþ-ATPases. Blocking
Ca2þ influx using Dz thus abolishes NAD(P)H oscillations
in this model, as for the Keizer-Magnus model. Thus,
although the nature of the coupling is very different in these
two models, the predicted responses to Dz are the same.
We next examined the DOM (see Materials and Methods)
(34). In addition to a glycolytic oscillator, the DOM has an
electrical oscillator driven by the feedback of cytosolic
Ca2þ onto Ca2þ-activated Kþ channels (45,46). This electrical oscillator, which is similar to that used to produce the
[Ca2þ]i oscillations depicted in Fig. 1, A and B, and equivalent to the simplest form of the Keizer-Magnus model (13),
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FIGURE 1 Simulated effects of the KATP channelopener Dz on [Ca2þ]i and metabolic oscillations with
several mathematical models. [Ca2þ]i is the free cytosolic
Ca2þ concentration, ADP is the free cytosolic ADP concentration, and NADHm is the mitochondrial NADH concentration. (A) [Ca2þ]i and ADP for a model equivalent to
the Keizer-Magnus model (13). ADP oscillations are abolished by Dz. (B) [Ca2þ]i and ADP for the model of
Fridlyand et al. (32). ADP oscillations are abolished by
Dz. (C and D) Results with the DOM. The glucokinase
reaction rate parameter JGK in C is smaller than in D, but
otherwise the models are identical. The metabolic oscillations in C persist with smaller amplitude when Dz is
applied (all KATP channels put into an open state), whereas
in D the metabolic oscillations are terminated. Parameter
values that differ from those in Bertram et al. (34) are
JGK ¼ 470 mM ms1, k4 ¼ 330 mM, gK(Ca) ¼ 250 pS,
gK(Ca) ¼ 11,000 pS, and gk ¼ 2000 pS. Parameter values
in D are the same as in C, except JGK ¼ 530 mM ms1.
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produces fast bursts of electrical activity (period <1 min)
that are clustered into slower episodes by the glycolytic
oscillator, producing compound bursting in [Ca2þ]i (40,47–
49). The model can also produce pure slow oscillations
having the same response to Dz (not shown). Fig. 1, C and
D, show compound Ca2þ oscillations produced using this
model for two different values of the glucokinase reaction
rate, JGK. The slow component of the oscillations reflects
glycolytic oscillations, which feed into mitochondrial metabolism to produce oscillations in NADH (NADHm) and ultimately, ATP. Dz again immediately hyperpolarizes the
model islet, and cytosolic Ca2þ approaches a low basal level.
The response of the metabolic oscillations to the cessation of
Ca2þ oscillations, however, is different for the two islets
simulated with the DOM. In one case (Fig. 1 C), NADHm
oscillations continue despite the continued presence of Dz,
although they are reduced in amplitude. The metabolic oscillations persist because they are intrinsic, and reflect oscillatory glycolysis, which is not directly Ca2þ dependent. In
the other case (Fig. 1 D), the NADHm oscillations eventually
dampen out when Ca2þ flux into the cell is abolished, so
a loss of the Ca2þ oscillations in this case results in the cessation of metabolic oscillations. Here the metabolic oscillations
are based on the same mechanism as in the simulation shown
in Fig. 1 C, but they cease because Dz lowers mean cytosolic
Ca2þ, which in turn reduces ATP use by the Ca2þ pumps,
raising the ATP/ADP ratio (29) and inhibiting PFK-1 (50).
Whether blocking Ca2þ entry inhibits PFK-1-mediated
metabolic oscillations or not in the DOM depends on the
balance between PFK-1 inhibition by ATP and PFK-1 activation by its substrate. The two model islets shown in the
figure differ in only one parameter value, the glucokinase
reaction rate (JGK), which is larger in Fig. 1 D, leading to
a larger mean ATP level, which in turn is able to suppress
PFK-1-mediated oscillatory activity. The value of JGK would
depend on the glucose concentration and the level of glucokinase activity. Changes in other parameters (not shown),
such as ones that affect the sensitivity of PFK-1 to ATP,
can also convert a model islet with persistent metabolic oscillations (Fig. 1 C) into one in which oscillations die out after
blocking Ca2þ entry (Fig. 1 D). We reiterate that in all other
models published to date, with the exception of MacDonald
et al. (28), the occurrence of Ca2þ oscillations is absolutely
essential for metabolic oscillations to occur (25,26,29–32).
Thus, finding intrinsic metabolic oscillations that persist
when Ca2þ oscillations are abolished is an important prediction of the DOM (34,37).
The modeling shown in Fig. 2 shows further that the
persistence of NADHm oscillations is determined by the
effects of ATP on PFK-1, which in turn depends on the level
of Ca2þ and hence ATP use. Whereas this figure begins similarly to Fig. 1 D in that Dz abolishes NADHm oscillations, in
this case, KCl was increased after 60 min, raising the Kþ
equilibrium potential from 75 mV to 50 mV. This raises
cytosolic Ca2þ (Fig. 2 A) and in turn lowers ATP (Fig. 2 B).
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FIGURE 2 Predicted restoration of NADHm oscillations. Continuation of
simulation in Fig. 1 D with KCl added at t ¼ 60 min, simulated by raising the
Kþ reversal potential from 75 mV to 50 mV. The rise in [Ca2þ]i (A)
decreases free cytosolic ATP (B) and disinhibits PFK-1, which restores
oscillations in NADHm (C).

The consequent disinhibition of PFK-1 as ATP falls allows
NADHm oscillations to resume (Fig. 2 C). If KCl were raised
further, ATP levels would be depressed further, and PFK-1
would be activated so strongly that it would stay on and
no oscillations would be produced (not shown). Thus, the
DOM predicts that increasing [Ca2þ]i within a range of
values should restore NADHm oscillations in islets where
they had been terminated initially by diazoxide application.
Metabolic oscillations can persist without [Ca2þ]i
oscillations
To test these predictions, slow oscillations in islet fuel
metabolism were monitored by recording endogenous islet
autofluorescence to 365 nm light, which reflects production
of the reduced coenzymes NADH and NADPH, collectively
referred to as NAD(P)H (18,41,51). Fig. 3 A shows representative slow NAD(P)H oscillations in six islets in 11.1 mM
glucose. Simultaneous recording indicates the islets oscillated asynchronously. FFT was applied to each NAD(P)H
time series to determine the underlying period. In 11.1 mM
glucose, the dominant period of islet NAD(P)H oscillations
was, on average, 5.9 5 0.1 min, with a median of 5.3 min
(n ¼ 133 islets). This value is in good agreement with the
previously reported period of 5.1 5 0.1 min (18). The oscillations were metabolic in origin as they were reversibly
blocked by the glucokinase inhibitor D-mannoheptulose
(5 mM) (Fig. S1 in the Supporting Material).
Biophysical Journal 99(1) 76–84
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FIGURE 3 Islet NAD(P)H oscillations can occur without [Ca2þ]i
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As shown in Fig. 3 B, the application of 200 mM Dz
promptly abolished islet [Ca2þ]i oscillations. Under these
conditions, stepwise increases in extracellular Kþ from
5 to 10, 15, and 30 mM, elevated mean [Ca2þ]i, as expected,
but did not restore [Ca2þ]i oscillations. In parallel experiments monitoring NAD(P)H, 200 mM Dz was applied to
islets exhibiting slow metabolic oscillations in 11.1 mM
glucose (Fig. 3, C and D). Two distinct types of islet
responses to Dz were observed, as confirmed by FFT: 1),
loss of NAD(P)H oscillations; and 2), persistent NAD(P)H
oscillations having reduced amplitude.
Of 101 islets, 34 (34%) exhibited NAD(P)H oscillations
that persisted in 200 mM Dz, as in Fig. 3 C, although their
amplitude was typically reduced to ~25% of controls. Interestingly, although NAD(P)H oscillations in separate islets
were initially asynchronous, oscillations were synchronized
by Dz (n ¼ 203 islets, measured in 33 independent experiments). Dz-induced synchronization of the islet metabolic
oscillations is consistent with our observation that Dz
similarly synchronized the Ca2þ oscillations of independent
islets (52) (see also Fig. 5). Because of synchronization, we
were able to increase the signal/noise ratio by analyzing
averaged NAD(P)H fluorescence when Dz was present. In
Fig. 3 C, middle, the averaged NAD(P)H oscillations from
three islets measured in a single experiment are shown on
an expanded scale to demonstrate their resemblance to the
corresponding oscillations measured before Dz application
(Fig. 3 C, left). FFT (exemplified by islet 3 in Fig. 3 C, right)
indicated the period of these slow oscillations was not
changed by Dz (pre-Dz, 6.1 5 0.3 min; post-Dz, 5.6 5
Biophysical Journal 99(1) 76–84

0.3 min; n ¼ 34, p ¼ 0.29 in a paired, two-tailed t-test).
These data thus show that metabolic oscillations can occur
in the complete absence of [Ca2þ]i oscillations, indicating
that they have an independent origin in at least a subset of
islets. The DOM reproduces this behavior, including the
reduction in the amplitude of NAD(P)H oscillations seen
experimentally in the presence of Dz (Fig. 1 C).
For the remaining islets (67 of 101), Dz addition eliminated NAD(P)H oscillations (as in Fig. 3 D), as confirmed
by FFT. The elimination of metabolic oscillations by Dz is
consistent with previous reports (15,18).
One possible explanation for our finding that in some islet
oscillations were eliminated whereas in others they persisted
is simply that in some but not all islets Ca2þ oscillations are
required for metabolic oscillations. However, as discussed
earlier, in the DOM, metabolic oscillations are intrinsic to
islets. They are eliminated by Dz because glycolytic PFK-1
is allosterically inhibited by the ATP that builds up as
Ca2þ-ATPases switch off when the [Ca2þ]i level falls sufficiently. The model then predicts that even if an islet is in
a nonoscillatory state, a subsequent rise in Ca2þ could restore
Ca2þ-ATPase activity by triggering increased consumption
of ATP, disinhibiting PFK-1, and in turn restoring the metabolic oscillations (Fig. 2). When we tested this prediction by
elevating extracellular KCl from 5 to 15 mM, which raised
[Ca2þ]i as shown in Fig. 3 B, NAD(P)H oscillations again
became evident and persisted for >20 min despite the
continued presence of Dz (see Fig. 3 E, a continuation of
the recording in Fig. 3 D). Oscillations were restored in
54% of islets (26 of 47) in which KCl was elevated in the
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presence of Dz. This finding thus confirms what we believe
to be a novel and, to date, unique prediction of the DOM.
Given the evidence for an intrinsic metabolic oscillator in
islets, we reasoned that nonpharmacologic manipulations
that decouple ionic from metabolic oscillations should
produce similar results to those using Dz. Genetic loss of
sulfonylurea receptor 1 (SUR1), a subunit of the KATP
channel, results in b-cells in which electrical activity becomes
uncoupled from fuel metabolism, and by extension, metabolic
oscillations. To show this decoupling, we measured membrane potential (Vm) and [Ca2þ]i in islets from SUR1/
and SUR1þ/þ littermate controls. As shown in Fig. 4 A,
slow bursting in Vm was observed in SUR1þ/þ islets (period ¼
3.7 5 0.4 min, n ¼ 8) bathed in 11.1 mM glucose, whereas
only continuous fast Vm spiking was observed in SUR1/
islets that were cultured overnight in media containing
11.1 mM glucose (n ¼ 8). SUR1/ islets (n ¼ 8) also lacked
[Ca2þ]i oscillations in 11.1 mM glucose under these conditions (Fig. 4 B). Culturing the islets overnight was critical to
the experiment because we observed oscillations in electrical
activity and [Ca2þ]i in SUR1/ islets cultured for %4 h
(Fig. S2); this finding has been reported previously (53,54).
In contrast, wild-type islets exhibited [Ca2þ]i oscillations
having a period of 3.9 5 0.1 min (n ¼ 13); this was not
changed by overnight culturing. Most importantly, Fig. 4 C
illustrates that slow oscillations in NAD(P)H in the SUR1þ/þ
islets (4.9 5 0.4 min, n ¼ 17, p > 0.05) were not significantly
different from those observed in SUR1/ islets (period ¼
4.4 5 0.3 min, n ¼ 19), despite the absence of [Ca2þ]i oscillations in these islets.
Thus, the data show that islet metabolic oscillations can
persist whether islet [Ca2þ]i oscillations are abolished pharmacologically or via genetic loss of KATP channels, suggestA
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FIGURE 4 SUR1-null islets lacking functional KATP channels exhibit
metabolic but not electrical oscillations. Representative recordings of (A)
membrane potential (Vm) (n ¼ 8), (B) [Ca2þ]i (340:380 ratio) (n ¼ 13),
and (C) NAD(P)H fluorescence (n ¼ 19 and 17, respectively) are shown
for SUR1/ and SUR1þ/þ control islets, as indicated. All recordings
were carried out in 11.1 mM glucose.

ing that the metabolic oscillator can function autonomously.
We noted that these two sets of experiments differ in that
the application of Dz results in low, nonoscillatory [Ca2þ]i,
whereas SUR1/ islets exhibit high, nonoscillatory [Ca2þ]i
(243 5 20 nM in 2.8 mM glucose) as compared to controls
(72 5 11 nM in 2.8 mM glucose, p < 0.0001 in a two-tailed
t-test, n ¼ 8–12). Therefore, to more fully examine this point,
we next tested the effects of elevated steady-state [Ca2þ]i on
slow NAD(P)H oscillations.
Increases in nonoscillatory [Ca2þ]i and glucose
modulate the slow metabolic oscillations
Whereas the data above show that [Ca2þ]i oscillations are not
mandatory for islet metabolic oscillations to occur, we
observed that changing [Ca2þ]i levels modulated the
NAD(P)H oscillations of the islets (Fig. 5 A). Moderate elevations in nonoscillatory [Ca2þ]i were achieved by increasing
[Kþ]o from 5 to 15 mM (see Fig. 3 B) in the presence of Dz
and 11.1 mM glucose. [Ca2þ]i elevation did not change the
period ([Kþ]o¼ 5 mM, 5.6 5 0.3 min; [Kþ]o¼ 15 mM, 5.0 5
0.4 min; n ¼ 14; p ¼ 0.054) or amplitude ([Kþ]o¼ 5 mM,
264 5 26 a.u.; [Kþ]o¼ 15 mM, 288 5 24 a.u.; n ¼ 13;
p ¼ 0.82) of the NAD(P)H oscillations. However, increasing
[Kþ]o to 30 mM produced a large transient rise of NAD(P)H,
followed by a fall and then the resumption of oscillations
exhibiting a ~60% increase in both frequency (period ¼
3.2 5 0.1 min; p ¼ 0.010 in a paired, two-tailed t-test;
n ¼ 13) and amplitude (456 5 48 a.u.; p ¼ 0.008; n ¼ 13).
This indicates that although Ca2þ oscillations were not required for the production of metabolic oscillations, increasing
the Ca2þ level strongly enhanced them.
Finally, islets were first bathed in 2.8 mM glucose with Dz,
and then glucose was increased to 11.1 mM while keeping Dz
present (Fig. 5 B). This design allowed the metabolic effects
of glucose to be tested in the absence of KATP-channel closure,
and hence the absence of [Ca2þ]i oscillations. Under this
condition, only weak aperiodic fluctuations in baseline
NAD(P)H fluorescence were apparent in 2.8 mM glucose
and 200 mM Dz. We have observed NAD(P)H oscillations
in 2.8 mM glucose (not shown), but because the magnitude
is likely to be further reduced by Dz, NAD(P)H oscillations
in 2.8 mM glucose and Dz may be below the detection limit.
Nonetheless, stimulating metabolism with 11.1 mM glucose
resulted in a sharp increase in NAD(P)H fluorescence (41 5
0.02%; n ¼ 27) with superimposed NAD(P)H oscillations.
This result further supports the hypothesis that oscillatory
NAD(P)H does not require oscillatory [Ca2þ]i, and suggests
that the metabolic oscillations that occur in the absence of
[Ca2þ]i oscillations still require elevated glucose, as expected.
DISCUSSION
Insulin secretion depends jointly on two distinct but interrelated b-cell functions, cytosolic Ca2þ homeostasis and
Biophysical Journal 99(1) 76–84
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FIGURE 5 NAD(P)H oscillations are modulated by elevations of nonoscillatory [Ca2þ]i or glucose. (A) Effect of elevating nonoscillatory [Ca2þ]i
on slow NAD(P)H oscillations measured in the continuous presence of
11.1 mM glucose and 200 mM Dz. [Ca2þ]i was elevated by increasing
[Kþ]o in the bath as in Fig. 3 B. The representative trace is an average of
four synchronized islets in the same chamber (in total, 13 islets were
recorded in three independent experiments). The raw data traces are
provided in Fig. S3 to illustrate islet synchronization. (B) Averaged change
in islet NAD(P)H fluorescence from eight synchronized islets in the same
recording chamber when glucose was elevated from 2.8 to 11.1 mM in
the presence of 200 mM Dz to clamp islet [Ca2þ]i. Arrows indicate peaks
of NAD(P)H oscillations. Scale bar is displayed for the inset graph. Trace
is representative of 25 islets recorded in three independent experiments.

glucose metabolism. The Ca2þ component is largely shared
with the universal exocytotic machinery that operates in
hormone secretion from other endocrine cells and transmitter
release from neurons. The metabolic component is specific to
b-cells, which metabolize glucose and increase their ATP/
ADP ratio in accord with the plasma glucose concentration,
and not just their own metabolic requirements, befitting their
role as metabolic sensors for the organism. Although the
interrelationship between Ca2þ and metabolism is complex
and unlikely to be completely dissociable, using the DOM
as a tool for predicting islet oscillatory behavior, we sought
experiments to rectify disagreement over which serves a
pacemaker-like function.
Biophysical Journal 99(1) 76–84

Using endogenous NAD(P)H fluorescence, we analyzed
the effects of abolishing islet [Ca2þ]i oscillations with Dz
on islet metabolic oscillations. In many of the islets (34%)
the metabolic oscillations persisted in the complete absence
of Ca2þ oscillations. In the remainder (66%), Dz eliminated
the metabolic oscillations, but increases in steady-state
[Ca2þ]i produced by raising [KCl] could, in most cases
(26 of 47 tested; 54%), restore the metabolic oscillations.
Although Ca2þ and NAD(P)H were not measured simultaneously, the [Ca2þ]i oscillations were invariably eliminated
by Dz. Therefore, [Ca2þ]i oscillations are not required to
produce islet metabolic oscillations in islets. This is further
supported by our demonstration that NAD(P)H oscillations
persisted in SUR1-null mice, which lack the KATP channels
that serve as the main metabolic sensor of the b-cell, and
therefore lack Ca2þ and electrical oscillations under the
experimental conditions we used.
Moreover, the finding that metabolic oscillations can
occur in the absence of Ca2þ oscillations is consistent with
models in which the b-cell metabolic oscillator is glycolytic
in origin (34–37). In contrast, the data are inconsistent with
the class of islet models in which metabolic oscillations are
driven exclusively by Ca2þ feedback (25,26,29–32), because
in these models terminating the Ca2þ oscillations necessarily
terminates the metabolic oscillations. Whereas we showed
previously (34) that the observation that Dz abolishes oscillations in metabolic variables such as oxygen consumption
or NAD(P)H does not rule out oscillations intrinsic to metabolism, this study shows that models in which metabolic oscillations are secondary to [Ca2þ]i oscillations are incorrect, or
at best incomplete. However, those models may still be
viable candidates for the electrical subcomponent of the
DOM. Indeed, our model contains a form of the Keizer-Magnus model as a submodel. In Keizer-Magnus, the influx of
Ca2þ reduces ATP/ADP, leading in turn to the opening of
KATP channels. In our view, this is part of the ionic or electrical component, which can coexist with the slow, intrinsic
metabolic oscillatory mechanism.
Although we have shown that [Ca2þ]i oscillations are not
necessary for the production of metabolic oscillations, Ca2þ
was found to be an important modulator of the oscillations.
For example, in those islets in which metabolic oscillations
persisted in the presence of Dz, their amplitude was reduced,
consistent with the predictions of the DOM. When the islets
were subsequently depolarized with 30 mM [Kþ]o, leading
to an increase in mean [Ca2þ]i, the amplitude of the
NAD(P)H oscillations correspondingly increased. Clearly,
then, the [Ca2þ]i level has a significant influence on islet
metabolic oscillations, even if it is not the driver of those
oscillations. These observations confirm an additional
specific prediction of the DOM, and are in good agreement
with a large body of literature indicating that [Ca2þ]i can
strongly amplify metabolism. In other studies, oscillations
in O2 consumption were similarly reduced in amplitude by
the removal of external Ca2þ (in HIT b-cells) (55) or by
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blocking L-type Ca2þ channels with nifedipine (in mouse
islets) (56). The observed effect of Ca2þ to enhance metabolic oscillations is not surprising, because Ca2þ activates
mitochondrial dehydrogenases (27,28). Ca2þ flux across
the mitochondrial inner membrane can also reduce mitochondrial membrane potential, diminishing ATP/NADH
production (25,26). Equally important in our model is the
direct relationship between ATP consumption via Ca2þATPases (29,30) and the activity of PFK-1 and glycolytic
flux (35). Through these mechanisms, [Ca2þ]i need not oscillate but may need to be elevated for robust metabolism,
which is illustrated by our demonstration that oscillations
could be restored by a moderate elevation of Ca2þ in those
islets in which the slow NAD(P)H oscillations were initially
abolished by Dz. In addition, we make no claim to have
proven that islet metabolic oscillations are glycolytic, as
the slow oscillations in NAD(P)H we observed experimentally could in principle reflect either glycolytic or mitochondrial processes (42). However, the results are consistent with
the DOM, in which metabolic oscillations generated by
glycolysis are amplified via the mitochondria, and argue
strongly against any model that excludes a role for intrinsic
metabolic oscillations.
In summary, we have shown that the pacemaker that
underlies slow islet oscillations is metabolic in origin rather
than Ca2þ-driven. This does not mean that Ca2þ is unimportant, as it was found to enhance the metabolic oscillations, is
the trigger for insulin granule exocytosis, and provides feedback onto b-cell Kþ channels that are most likely responsible
for the bursts of electrical activity that are clustered into
episodes by the metabolic oscillator (34,37). As raising
Ca2þ triggers exocytosis (e.g., using sulfonylureas or KCl)
but is insufficient for full activation of sustained insulin
secretion (57), an integrated view of the interrelationships
of islet Ca2þ and metabolism will be essential for the development of balanced secretagogue therapy for the successful
treatment of patients with diabetes.
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45. Göpel, S. O., T. Kanno, ., P. Rorsman. 1999. Activation of Ca(2þ)dependent K(þ) channels contributes to rhythmic firing of action potentials in mouse pancreatic b cells. J. Gen. Physiol. 114:759–770.
46. Goforth, P. B., R. Bertram, ., L. S. Satin. 2002. Calcium-activated Kþ
channels of mouse b-cells are controlled by both store and cytoplasmic
Ca2þ: experimental and theoretical studies. J. Gen. Physiol. 130:
307–322.
47. Beauvois, M. C., C. Merezak, ., P. Gilon. 2006. Glucose-induced
mixed [Ca2þ]c oscillations in mouse b-cells are controlled by the
membrane potential and the SERCA3 Ca2þ-ATPase of the endoplasmic
reticulum. Am. J. Physiol. 290:C1503–C1511.
48. Bergsten, P., E. Grapengiesser, ., B. Hellman. 1994. Synchronous
oscillations of cytoplasmic Ca2þ and insulin release in glucose-stimulated pancreatic islets. J. Biol. Chem. 269:8749–8753.

33. Fridlyand, L. E., L. Ma, and L. H. Philipson. 2005. Adenine nucleotide
regulation in pancreatic beta-cells: modeling of ATP/ADP-Ca2þ interactions. Am. J. Physiol. Endocrinol. Metab. 289:E839–E848.

49. Valdeolmillos, M., R. M. Santos, ., L. M. Rosario. 1989. Glucoseinduced oscillations of intracellular Ca2þ concentration resembling
bursting electrical activity in single mouse islets of Langerhans. FEBS
Lett. 259:19–23.

34. Bertram, R., L. S. Satin, ., A. Sherman. 2007. Interaction of glycolysis
and mitochondrial respiration in metabolic oscillations of pancreatic
islets. Biophys. J. 92:1544–1555.

50. Tornheim, K., and J. M. Lowenstein. 1974. The purine nucleotide cycle.
IV. Interactions with oscillations of the glycolytic pathway in muscle
extracts. J. Biol. Chem. 249:3241–3247.

35. Tornheim, K. 1997. Are metabolic oscillations responsible for normal
oscillatory insulin secretion? Diabetes. 46:1375–1380.

51. Bennett, B. D., T. L. Jetton, ., D. W. Piston. 1996. Quantitative subcellular imaging of glucose metabolism within intact pancreatic islets.
J. Biol. Chem. 271:3647–3651.

36. Tornheim, K. 1979. Oscillations of the glycolytic pathway and the
purine nucleotide cycle. J. Theor. Biol. 79:491–541.
37. Bertram, R., A. Sherman, and L. S. Satin. 2007. Metabolic and electrical
oscillations: partners in controlling pulsatile insulin secretion. Am.
J. Physiol. 293:E890–E900.
38. Dryselius, S., P. E. Lund, ., B. Hellman. 1994. Variations in ATPsensitive Kþ channel activity provide evidence for inherent metabolic
oscillations in pancreatic beta-cells. Biochem. Biophys. Res. Commun.
205:880–885.
39. Shiota, C., O. Larsson, ., M. A. Magnuson. 2002. Sulfonylurea
receptor type 1 knock-out mice have intact feeding-stimulated insulin
secretion despite marked impairment in their response to glucose.
J. Biol. Chem. 277:37176–37183.
40. Zhang, M., P. Goforth, ., L. Satin. 2003. The Ca2þ dynamics of isolated mouse b-cells and islets: implications for mathematical models.
Biophys. J. 84:2852–2870.
41. Rocheleau, J. V., W. S. Head, and D. W. Piston. 2004. Quantitative
NAD(P)H/flavoprotein autofluorescence imaging reveals metabolic

Biophysical Journal 99(1) 76–84

52. Zhang, M., B. Fendler, ., L. Satin. 2008. Long lasting synchronization
of calcium oscillations by cholinergic stimulation in isolated pancreatic
islets. Biophys. J. 95:4676–4688.
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